chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Nausea
Clinical narrative: Chest pain (towards left side); Nausea; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old, non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 22Oct2021 at 18:00 in the left arm (at the age of 40-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history and had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other concomitant medications within two weeks prior to the vaccination. On 25Oct2021, at 10:00, the patient experienced chest pain (towards left side) and nausea. No therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chest pain (towards left side) and nausea was unknown at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective, Rheumatoid factor, SARS-CoV-2 test
Clinical narrative: patient tested positive for COVID and subsequently again stopped the medication; patient tested positive for COVID and subsequently again stopped the medication; This is a spontaneous report from a contactable consumer.   A 72-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number was not reported), via an unspecified route of administration on unspecified date as dose 1, single and second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number was not reported), via an unspecified route of administration on 06May2021 as dose 2, single for COVID-19 immunisation. Medical history included ongoing rheumatoid arthritis without rheumatoid factor, right hand. Concomitant medication included etanercept (ENBREL) taken 50 milligrams, weekly (lot number: 1133614, Expiration Date: 31Oct2023) for rheumatoid arthritis, start and stop date on May2021. On 21Aug2021 patient tested COVID positive while receiving Enbrel with Single Dose Prefilled Autoinjector.  No treatment information was received. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Limb discomfort, Muscle spasms, Pain, Pollakiuria, Urine output
Clinical narrative: charlie horse in both calves; pain was ' out of control'; 'calf muscles felt like it was going to explode'; urinating all night non stop; This is a spontaneous report from a non-contactable consumer or other non HCP (patient).  A 67-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number and expiration date was not reported), via an unspecified route of administration on 24Feb2021 (Age at vaccination was 67 years) as dose 1, single for covid-19 immunisation. Medical history included drug hypersensitivity (Penicillin allergy) from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. After received first dose of Pfizer COVID vaccine yesterday on 24Feb2021 and later in the evening patient experienced Charlie horse in both calves. Patient also experienced pain which was out of control and his calf muscles felt like it was going to explode. The patient had pain for 2 hours. Also reports he has been urinating all night non-stop despite not drinking anything. He was continuing to urinate every 15 minutes. States he had never experienced anything like this and there was nothing wrong with his prostate. Patient notified his health care professional (HCP) and was told that if he continues to urinate like that he may have to see a urologist urgently. It was also reported that patient won't take the second dose because of this (his reaction to the vaccine-captured in first request), he feels like the vaccine was not safe. Reports that his HCP said he don't know what the hell was in the vaccines and until we know he don't think it's safe to take. On an unspecified date the patient underwent lab tests and procedures which included urine output with result urinating all night non-stop, Also reports he had urinating all night non-stop despite not drinking anything. He was continuing to urinate every 15 mins. The patient received Advil as therapeutic measure for Charley horse, pain, Calf discomfort. On an unspecified date in 2021 patient was recovered from pain and outcome of rest of all events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Hypersomnia, Influenza like illness, Memory impairment
Clinical narrative: Slept all day; fussy memory; severe headaches; Flu like symptoms; tired; swollen arm at vaccine site; This is a spontaneous report from a contactable consumer or other non hcp (Patient). A 78-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch number/Lot Number: EL9260), via an unspecified route of administration, administered in Arm Left on 18Feb2021, at 18:00 (Age at vaccination 78-years-old), as DOSE 2, SINGLE for covid-19 immunization. Medical history included diabetes mellitus from an unknown date and unknown if ongoing. Concomitant medications included atorvastatin (ATORVASTATIN), lisinopril (LISINOPRIL) taken for an unspecified indication, start and stop date were not reported. Patient did not receive other vaccine in four weeks. Patient did not have covid-19 prior to vaccination. Patient not tested for covid post vaccination. Patient did not have known allergies. The male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch number/Lot Number: EL8982), via an unspecified route of administration, administered in Arm Left on 25Jan2021, at 01:00 PM, as DOSE 1, SINGLE for covid-19 immunization. On 19Feb2021, the patient experienced swollen arm at vaccine site, on 20Feb2021, the patient experienced flu like symptoms, tired, on 21Feb2021, the patient slept all day, fussy memory, severe headaches. Therapeutic measures were not taken as a result of the events except the event severe headaches and patient took tylenol to relieve headaches. Ibuprofen did not work, on sixth day patient was able to resume activities had active night dreams felt like 48 hours of regular Flu. The clinical outcome of the events was recovered on unspecified date.   No follow-up attempts are possible. No further information is expected.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Slept all day; fussy memory; severe headaches; Flu like symptoms; tired; swollen arm at vaccine site; This is a spontaneous report from a contactable consumer or other non hcp (Patient). A 78-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch number/Lot Number: EL9260), via an unspecified route of administration, administered in Arm Left on 18Feb2021, at 18:00 (Age at vaccination 78-years-old), as DOSE 2, SINGLE for covid-19 immunization. Medical history included diabetes mellitus from an unknown date and unknown if ongoing. Concomitant medications included atorvastatin (ATORVASTATIN), lisinopril (LISINOPRIL) taken for an unspecified indication, start and stop date were not reported. Patient did not receive other vaccine in four weeks. Patient did not have covid-19 prior to vaccination. Patient not tested for covid post vaccination. Patient did not have known allergies. The male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch number/Lot Number: EL8982), via an unspecified route of administration, administered in Arm Left on 25Jan2021, at 01:00 PM, as DOSE 1, SINGLE for covid-19 immunization. On 19Feb2021, the patient experienced swollen arm at vaccine site, on 20Feb2021, the patient experienced flu like symptoms, tired, on 21Feb2021, the patient slept all day, fussy memory, severe headaches. Therapeutic measures were not taken as a result of the events except the event severe headaches and patient took tylenol to relieve headaches. Ibuprofen did not work, on sixth day patient was able to resume activities had active night dreams felt like 48 hours of regular Flu. The clinical outcome of the events was recovered on unspecified date.   No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Nasopharyngitis
Clinical narrative: Head cold; abdominal pain; This is a spontaneous report from a contactable consumer or other non hcp. A 70-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported) dose via an unspecified route of administration on an unspecified date as Dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced head cold that lasted over a week. The head cold was not COVID as he tested negative, and he stated he reported the abdominal pain that night to. A 70 year old male consumer was due for his second dose of Pfizer's COVID vaccine tomorrow, 26Feb2021. After his first dose, he had pretty intense abdominal pains and aches the night of the first shot and lingering. He stated it even came back now a little. Caller also stated he read that some of the 35 hospitalizations from the vaccine were due to abdominal pain. Caller also stated he just got over a head cold that lasted over a week. The head cold was not COVID as he tested negative and he stated he reported the abdominal pain that night to (App name withheld). Caller also stated he knows of 2 other people that had a head cold 2 weeks after receiving the vaccine and would like to report that. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Chills, Dry mouth, Feeling abnormal, Illness
Clinical narrative: chills; swollen lymph nodes in neck; mouth dry; stomach pain; not feeling well-felt warm; tingling in legs; body aches; generally feeling unwell; pain at injection site; she felt like it knocked her down; ;made her feel sick; This is a spontaneous report from a non-contactable consumer (patient).   A 76-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: not reported), via an unspecified route of administration on 24Feb2021 as dose 2, single for covid-19 immunization. Patient had no relevant medical history. The patient concomitant medications were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1, on an unspecified date for covid-19 immunization. Recently received 2nd dose of pfizer covid vaccine yesterday and experienced side effects: pain at injection site, chills, swollen lymph nodes in neck, mouth dry, stomach pain, not feeling well-felt warm; body aches; tingling in legs and generally feeling unwell. Caller did not know whether to be concerned. Asking if what the patient feeling was normal. Had no issues at all with the first dose. With the second dose, the patient felt like it knocked her down; made her feel sick. The outcome of the events was unknown.   No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Malaise, Pain, Paraesthesia, Vaccination site pain
Clinical narrative: chills; swollen lymph nodes in neck; mouth dry; stomach pain; not feeling well-felt warm; tingling in legs; body aches; generally feeling unwell; pain at injection site; she felt like it knocked her down; ;made her feel sick; This is a spontaneous report from a non-contactable consumer (patient).   A 76-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: not reported), via an unspecified route of administration on 24Feb2021 as dose 2, single for covid-19 immunization. Patient had no relevant medical history. The patient concomitant medications were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1, on an unspecified date for covid-19 immunization. Recently received 2nd dose of pfizer covid vaccine yesterday and experienced side effects: pain at injection site, chills, swollen lymph nodes in neck, mouth dry, stomach pain, not feeling well-felt warm; body aches; tingling in legs and generally feeling unwell. Caller did not know whether to be concerned. Asking if what the patient feeling was normal. Had no issues at all with the first dose. With the second dose, the patient felt like it knocked her down; made her feel sick. The outcome of the events was unknown.   No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: arms didn't get painful or sore. Unless I press really hard on it,; This is a spontaneous report from a contactable consumer(patient). This 77-year female patient BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Lot number: EM9809, Expiration date: not reported) via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Reporter stated she received the first dose of the Pfizer vaccine on Monday morning and had no reactions at all. "My arms didn't get painful or sore. Unless I press really hard on it, I wouldn't know I got an injection" on an unspecified date. Reporter queried that Was it possible that she was given a dose that was not effective and assume there wasn't any issues; with them storing it, diluting it correctly. Outcome of the event was unknown.  No follow-up attempts are possible; information about batch/ lot number cannot be obtained.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Neck pain, Pain in extremity
Clinical narrative: Neck soreness; arm soreness; Extreme fatigue; This is a spontaneous report from a contactable consumer or other non hcp (patient).    A 61-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: 5318), via an unspecified route of administration, administered in Arm Left on 25Feb2021, at 06:45 (at the age of 61-years-old), as dose 2, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. Patient did not receive other vaccine in four weeks and other medications in two weeks. Patient had not been tested positive for covid and not tested post vaccination for covid. Patient did not have any known allergies. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: 5318), via an unspecified route of administration, administered in arm left on 04Feb2021, at 06: 30 (at the age of 61-years-old), as dose 1, single for covid-19 immunization. On 25Feb2021, at 06:45, the patient experienced neck soreness, arm soreness and extreme fatigue. The patient did not receive any treatment medication for adverse event. The outcome of the events was not recovered.   Follow-up attempts completed. No further information expected
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: both he and his girlfriend experienced arm soreness after the Pfizer Covid vaccine dose.; This is a spontaneous report from a contactable consumer (patient) reported for himself. A male patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: unknown, Expiration date: unknown), via an unspecified route of administration, administered at an unspecified anatomical location on an unspecified date as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were unknown. On an unspecified date the patient experienced both he and his girlfriend experienced arm soreness after the pfizer covid vaccine dose. The outcome of the events was unknown.  No Follow-up attempts are possible. Information about lot/batch cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Nasopharyngitis
Clinical narrative: Caller also stated he knows of 2 other people that had a head cold 2 weeks after receiving the vaccine and would like to report that; This is a spontaneous report from a contactable consumer or other non-health care professional via medical information team. This consumer reported similar events for 2 patients. This is 1st of 2 reports. A patient of unspecified age (Approximate symbol) 70 years) and gender received bnt162b2 (BNT162B2, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as dose number unknown, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date the reporter stated he knows of 2 other people that had a head cold 2 weeks after receiving the vaccine and would like to report that. Caller also wondering what happened to those 35 hospitalized patients after receiving the vaccine and had abdominal pain and if there had been any reports of death. The case was non-serious. Outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot been obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021214180 Same reporter, Different Patient
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Vertigo
Clinical narrative: nausea; vertigo; This is a spontaneous report from a Contactable consumer (Caregiver) via Medical Information Team. This consumer reported for her aunt (patient).   A female patient of (age: 89, Unit: Unknown) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration on 24Feb2021 (Batch/Lot number was not reported) as DOSE 2, SINGLE for COVID-19 immunisation. Medical history included vertigo and concomitant medications were not reported. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 1, SINGLE for COVID-19 immunisation. The reporter stated that her aunt (patient) received the Pfizer covid vaccine second dose on Wednesday, and she was having really bad nausea and vertigo (she has vertigo before also), her aunt could not get out of the bed due to it and was given her vertigo medication (treatment). The reporter wanted to know about it. The clinical outcome of event Vertigo was not recovered and of event nausea was unknown at the time of this report.   No follow-up attempts are possible; information about batch/ lot number cannot be obtained.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Fall, Gait disturbance, Limb discomfort
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 57-year-old male patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, solution for injection, batch/lot# EL9265, expiry date: unknown) at the vaccination age of 57, via an unspecified route of administration, in left arm, on Feb 5, 2021, at 16:30, single dose, for COVID-19 immunisation. Medical history included ongoing hypertension (high blood pressure). Additional information: patient diagnosed with high blood pressure 3-4 years ago. The only medication he takes is for high blood pressure. No additional vaccines administered on same date of Pfizer suspect. The patient's concomitant medications not reported. He did not receive any other vaccine within 4 weeks. On Feb 6, 2021, at 06:45, patient had leg dragging, heaviness in leg and his legs gave out from under him. Reportedly, patient had a weird experience after his first dose of COVID-19 vaccine. Patient said he was due to get his second COVID-19 vaccine shot later today (Feb 26, 2021). In the morning after his first COVID-19 vaccination, as he was walking to the bathroom after waking up, his legs felt heavy. He felt he was dragging his legs. All of a sudden, his legs gave out from under him. He slid down the wall and ended up on the floor. A minute later, he was able to stand up. Patient reported he did not have any other issues. He was not sure if what happened was related to the COVID-19 vaccine, or if his legs giving out was an anomaly. Patient said he wanted to get his second COVID-19 vaccine shot today and would like to know what Pfizer recommended. Patient did not visit emergency room/physician office as a result of events. The outcome of events recovered on Feb 6, 2021, at 6:46. No follow-up attempts needed. No further information expected.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Memory impairment
Clinical narrative: Recently my memory has failed a lot. I am blank; This is a spontaneous report from a contactable consumer (patient herself). A 79-years-old female patient received bnt162b2 (Pfizer-BioNTech COVID-19, solution for injection, Batch/Lot number not reported ) via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE (age at vaccination 79 years old) for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced recently my memory has failed a lot on an unspecified date with outcome of unknown.  No follow-up attempts are possible; Information about lot/batch number cannot been obtained.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Feeling abnormal, Pain, SARS-CoV-2 test
Clinical narrative: Injection site soreness; Body aches; Chills; Tiredness; Mental Fog; This is a spontaneous report from a contactable consumer (patient). A 33-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, lot number and Expiry date: unknown) administered in Arm Right on 24Feb2021 at 12:00 (age at the time of vaccination was 33 -year-old), as dose 2, single for COVID-19 immunization. The patient's medical history included Covid-19. The patient's concomitant medications were not reported. The patient did not take any other vaccine in four weeks prior COVID -19 vaccine. The patient was diagnosed with COVID prior vaccination and not tested with COVID post vaccination. The patient had no known allergies. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot Number: unknown, via an unspecified route of administration, administered in the right arm on 03Feb2021 at 12:00 (age at the time of vaccination was 33-year-old), as dose 1, single for COVID-19 immunization. On 25Feb2021, after the second dose of vaccine the patient experienced injection site soreness, body aches, chills, tiredness and mental fog. The patient underwent lab tests and procedures which included PCR covid test was positive prior vaccination on an unspecified date. Treatment received no for all the events. The outcome of the events was recovering.  No follow-up attempts were possible. Information about lot/batch number could not be obtained.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Injection site soreness; Body aches; Chills; Tiredness; Mental Fog; This is a spontaneous report from a contactable consumer (patient). A 33-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, lot number and Expiry date: unknown) administered in Arm Right on 24Feb2021 at 12:00 (age at the time of vaccination was 33 -year-old), as dose 2, single for COVID-19 immunization. The patient's medical history included Covid-19. The patient's concomitant medications were not reported. The patient did not take any other vaccine in four weeks prior COVID -19 vaccine. The patient was diagnosed with COVID prior vaccination and not tested with COVID post vaccination. The patient had no known allergies. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot Number: unknown, via an unspecified route of administration, administered in the right arm on 03Feb2021 at 12:00 (age at the time of vaccination was 33-year-old), as dose 1, single for COVID-19 immunization. On 25Feb2021, after the second dose of vaccine the patient experienced injection site soreness, body aches, chills, tiredness and mental fog. The patient underwent lab tests and procedures which included PCR covid test was positive prior vaccination on an unspecified date. Treatment received no for all the events. The outcome of the events was recovering.  No follow-up attempts were possible. Information about lot/batch number could not be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: pain in the left arm; This is a spontaneous report from a contactable consumer (patient herself). A female patient of an (age:74, unit: unknown) unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number and Expiry date was not reported), via an unspecified route of administration on 24Feb2021 as dose 2, single for COVID-19 immunization. Medical history included COVID-19 from Nov2020, there was blood clot on her right lung. The patient concomitant medications were not reported. The patient experienced pain in the left arm that lasted for 10-15 minutes after getting the 2nd dose. The outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot been obtained
Sex: F
Vaccine: COVID19
Symptoms: Needle issue, Underdose
Clinical narrative: was being administered, it sprayed on my face and rolled down my arm. If I didn't get the full amount, should I get another dose?; syringe they are using is the BD Syringe attached with  25 Gauge, 1 inch needle; This is a spontaneous report from a non-contactable consumer or other non hcp (patient). A female patient of an unspecified age received bnt162b2 (-PFIZER-BIONTECH COVID-19 mRNA vaccine, Solution for injection), dose 2 via an unspecified route of administration on 02Jan2021 (Batch/Lot number was not reported) as dose 2, single for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. On 02Jan2021, the patient stated when receiving the 2nd dose of the Pfizer covid vaccine, when it was being administered, it sprayed on her face and rolled down her arm. If she didn't get the full amount, she enquired, should she get another dose and or is there a way to test. The patient stated, she brought it up to infection control nurse several days ago. they said she had to talk to the Pharmacist. The Pharmacist spoke to nurse that administered and she said that she received the full dose. The nurse said she remembered giving it the needle came loose after administration, she was confident I received it. Patient stateds that the nurse said that the syringe they are using is the BD Syringe attached with 25 Gauge, 1inch needle, and that the biggest disadvantage is there is a lot of dead space, and that is why she felt this spray. The patient asked the Pharmacist why would it spray if it was under pressure, why would it spray at her. The pharmacist told her this information wasn't in his first report and he couldn't provide any more information. The patient stated, If it sprayed on her there was pressure on it and this was during administration, that is the way she felt. The outcome of the events was unknown.   No follow-up attempts are possible; information about batch/ lot number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia oral, Oral discomfort
Clinical narrative: her lips had a burning sensation and felt numb.; her lips had a burning sensation and felt numb.; This is a spontaneous report from a contactable pharmacist via medical information team.   A female patient of unspecified age received BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot/batch number and expiry date were not reported), via an unspecified route of administration, on an unspecified date, as a dose 2, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient historical vaccine includes BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot/batch number and expiry date were not reported), via an unspecified route of administration, on an unspecified date, as a dose 1, single for COVID-19 immunization. On an unspecified date, 15 minutes post vaccination after 2nd dose of Pfizer's COVID vaccine, her lips had a burning sensation and felt numb. Reportedly it was lasted for 30 minutes and that was it. The outcome of the event was recovered on an unspecified date.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Sex: M
Vaccine: COVID19
Symptoms: Pain in jaw
Clinical narrative: Jaw pain/ My neighbor said he had this too; This is a spontaneous report from a contactable reporter. This report is for reporter's neighbour. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; formulation: Solution for injection, Lot number was not reported), via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported he got a first dose of the vaccine and had some jaw pain. he had it a week ago Friday and it is kind of started Monday very mild and continually got worse. the neighbours said he had this too. The patient experienced jaw pain/ my neighbour said he had this too on an unspecified date. The clinical outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information expected.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site scab
Clinical narrative: has a scab at the injection site/the injection site still has a scab on it; This is a spontaneous report from a contactable Consumer. This female Consumer (patient reported for herself):  A 84-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Lot Number: Unknown), via unspecified route of administration, on an unspecified date as a dose 1, single for COVID-19 immunization. The patient medical history was not reported. The concomitant medication of the patient included carvedilol (CARVEDILOL) 12.5mg twice daily. On an unspecified date the patient experienced scab at the injection site/the injection site still has a scab on it. Patient reported that after receiving the first dose of the Pfizer Covid 19 vaccine she had a scab at the injection site that won't go away. Patient queried if this could be caused by her carvedilol (blood thinner) or if there are any contraindications to taking carvedilol with the vaccine. Patient also stated that she had heard a rumoured that the location where she received the first dose was not going to be giving the vaccine there anymore. The outcome for the reported event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Dysphagia, Magnetic resonance imaging, Musculoskeletal stiffness, Tenderness
Clinical narrative: Neck became stiff where he could not turn his head, or had difficulty moving his head; Trouble swallowing; Tenderness around the base of the skull on right side/Tenderness below the jawline on the right side/Tenderness down the right side of the neck; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 67-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection via an unspecified route of administration, administered in Left Arm on 23Feb2021 15:00 (Batch/Lot Number: EN6200, expiry date: unknown) as dose 1, single (age at vaccination:67-Years-old) for COVID-19 immunisation. Medical history included ongoing diabetes mellitus 25 years ago, around 40 years of age, ongoing hypertension 25 years ago, around 40 years of age. There were no concomitant medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Feb2021 16:00 the patient experienced neck became stiff where he could not turn his head, or had difficulty moving his head, trouble swallowing, tenderness around the base of the skull on right side/tenderness below the jawline on the right side/tenderness down the right side of the neck. This consumer was administered his first dose of the Pfizer COVID-19 Vaccine on 23Feb2021 around 15:00 and everything was fine. Starting 24Feb2021 around 16:00 his neck became stiff where he could not turn his head, or had difficulty moving his head; trouble swallowing; he also had, only on the right side: tenderness around the base of the skull on right side; tenderness below the jawline on the right side; and tenderness down the right side of the neck. He thinks the areas with the tenderness could be lymph nodes but he has never had problems with lymph nodes in the past. He asked if this is a normal effect of the Pfizer COVID-19 Vaccine or if it would be considered serious. The events not resulted in emergency room visit/ Physician office visit. On 04Feb2021 the patient underwent lab tests and procedures which included magnetic resonance imaging: bulging disc in lower back. The outcome of the events was reported as not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: I have soreness in my arm; This is a spontaneous report from a contactable consumer. A female consumer (patient) reported that:  A 62-years-old non-pregnant female patient (not pregnant at the time of vaccination) received BNT162B2 (PFIZER-BIONTECH COVID-19 Vaccine, solution for injection, Lot Number: EJ1685) via an unspecified route of administration, administered in Arm Right on 01Mar2021 17:00 (62-year-old at the time of vaccination) at a dose number unknown, single for covid-19 immunisation. Medical history included hypothyroidism (Synthroid 125mcg) and food allergy (sometimes egg yolk) from an unknown date and unknown if ongoing. Concomitant medication included levothyroxine sodium (SYNTHROID) for unknown indications from unknown dates and unknown if ongoing (medication the patient received within 2 weeks of vaccination). The patient had not received any vaccine within four weeks. The patient had no covid prior to vaccination. The patient was not tested since vaccination. On 02Mar2021, the patient experienced soreness in arm. The patient reported that her arm was sore for a couple of days after the vaccine. She was doing fine now. The patient received no treatment for the event. The outcome of the event was recovered on an unspecified date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache
Clinical narrative: Tired; Headache; Chills; This is a spontaneous report from a non-contactable consumer (patient). A 66-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: EN6202; Expiration Date: Jun2021), via an unspecified route, administered in Left Arm on 23Feb2021 (at the age of 66-year-old) as dose 2, single for covid-19 immunisation. The patient medical history was not reported. There were no concomitant medications. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: EL3302, Expiry date: May2021), via an unspecified route, administered in left arm on 02Feb2021 (at the age of 66-year-old) as dose 1, single for covid-19 immunisation and experienced headache for 48 hours. No other products. No Patient history. No Investigational assessment. No additional Vaccines Administered on Same Date of the Pfizer Suspect. No prior vaccinations (within 4 weeks) If applicable, list any other vaccinations within four weeks prior to the first administration date of the suspect vaccine. The patient states that with both vaccines first and second dose, experienced a strong headache for about 48 hours after, that each time it resolved in 48 hours. States with the second dose of the vaccine, had chills as well for about 48 hours, clarifies it was more that he was tired (on 23Feb2021) than chills. States first does was on 02Feb2021, and second dose was on 23Feb 2021. The adverse event did not require emergency room and Physician office visit. Outcome of event headache and chills was recovered in feb2021 and outcome of event tired was recovered on 25Feb2021.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021229933 same patient and drug, different dose and event
Sex: M
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A male patient, of an unspecified age, received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, solution for injection, batch/lot# not reported), via an unspecified route of administration, on Feb 24, 2021, single dose, for COVID-19 immunisation. The patient's medical history included ongoing chronic issues with hip and joints. Concomitant medications included oxycodone with paracetamol  for chronic issues with hip and joints. Patient avoided taking the oxycodone with Tylenol for the last couple of days because he had the second dose of Pfizer COVID-19 vaccine Feb 24, 2021. On Feb 25, 2021, patient had pain from the side effects he was told he would experience with the vaccine. His pain was pretty bad. He wanted to know if it was ok to take oxycodone with Tylenol after getting the Pfizer COVID-19 vaccine. The outcome of the event: unknown (at the time of report). No follow-up attempts needed. Information about batch/lot cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness
Clinical narrative: really terrible with flu like symptom; This is a spontaneous report from a contactable other hcp and Consumer or other non HCP.  A 48-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number and expiration date was not reported), via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. On an unspecified date the patient experienced really terrible with flu like after first vaccine so her Doctor of Medicine (MD) wanted to stop medication until after second dose to allow her body to recover. The outcome of event was unknown.  No follow-up attempts are needed. Information about Lot/Batch number cannot be obtained. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Headache, Ocular discomfort
Clinical narrative: This is a spontaneous report from a contactable consumer or other non-HCP (patient). A patient, of unspecified age and gender, received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, solution for injection, batch/lot# not reported), via an unspecified route of administration, on Feb 24, 2021, single dose, for COVID-19 immunization. The patient's medical and concomitant medications not reported. The patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, solution for injection, batch/lot# not reported), via an unspecified route of administration, on Feb 3, 2021, single dose, for COVID-19 immunization. On Feb 25, 2021, patient experienced dizziness, headache, heavy eyes and blurry vision. On an unspecified date in Feb 2021, patient experienced chills and fatigue. The chills lasted for 5 to 6 hours. On Feb 26, 2021, patient still felt fatigued but returning to normal. The outcome of chills and fatigue: recovering; of the other events: unknown. No follow-up attempts possible. Information about batch/lot number cannot been obtained.
Sex: U
Vaccine: COVID19
Symptoms: Vision blurred
Clinical narrative: This is a spontaneous report from a contactable consumer or other non-HCP (patient). A patient, of unspecified age and gender, received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, solution for injection, batch/lot# not reported), via an unspecified route of administration, on Feb 24, 2021, single dose, for COVID-19 immunization. The patient's medical and concomitant medications not reported. The patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, solution for injection, batch/lot# not reported), via an unspecified route of administration, on Feb 3, 2021, single dose, for COVID-19 immunization. On Feb 25, 2021, patient experienced dizziness, headache, heavy eyes and blurry vision. On an unspecified date in Feb 2021, patient experienced chills and fatigue. The chills lasted for 5 to 6 hours. On Feb 26, 2021, patient still felt fatigued but returning to normal. The outcome of chills and fatigue: recovering; of the other events: unknown. No follow-up attempts possible. Information about batch/lot number cannot been obtained.
Sex: M
Vaccine: COVID19
Symptoms: Pain, Tenderness
Clinical narrative: he experienced tenderness; pain; This is a spontaneous report from a Pfizer sponsored program Support from a contactable consumer (patient). A male patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: unknown, Expiration date: unknown), via an unspecified route of administration, administered at an unspecified anatomical location on 23Feb2021 as dose 1, single for COVID-19 immunization. The patient's medical history included stent placement (He has a stent on his heart) and coronary artery disease (Patient has Coronary Artery Disease) from an unknown date and unknown if ongoing. On an unspecified date in Feb2021 the patient experienced he experienced tenderness and pain. Patient wants to know if he still need to take the second dose. The outcome of the events was unknown.  No follow-up attempts are Possible. Information on lot/batch cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: soreness at the injection site; This is a spontaneous report from a contactable consumer or other non hcp. A adult male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot Number: UNKNOWN), via an unspecified route of administration on 26Feb2021 as dose 1, single for covid-19 immunisation. Medical history included cystic fibrosis from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. It was unknown that the patient receive any other vaccines within 4 weeks prior to the COVID vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. On 26Feb2021 the patient experienced soreness at the injection site. The patient did not received treatment for the adverse reaction. It was unknown if patient had been tested for COVID-19 since the vaccination. Outcome of the event was recovering.  No follow up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Loss of personal independence in daily activities, Pain in extremity
Clinical narrative: This is a spontaneous report from a contactable consumer. An 83-year-old female patient received the 1st dose of BNT162B2 (Comirnaty, solution for injection, batch/lot# not reported), via an unspecified route of administration, on Feb 24, 2021, at 01:00, single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. On an unspecified date, patient felt pain on back and legs, had difficulty getting out of bed/walking around and sore on the arm. The outcome of the events: unknown. No follow-up attempts possible. Information on batch/lot cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Amnesia
Clinical narrative: couldn't remember when she got her 1st dose and didn't clarify if her memory loss was due to getting the Covid vaccine; This is a spontaneous report from a Pfizer-sponsored program . A non-contactable female consumer (patient) of an unspecified age reported that she received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. It was reported that patient couldn't remember when she got first dose and it's not on any of her paperwork. On an unspecified date, the patient experienced couldn't remember when she got her 1st dose and didn't clarify if her memory loss was due to getting the Covid vaccine. The outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: Fatigue; sore arms; This is a spontaneous report from a contactable consumer (patient) received via a male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), dose 1 via an unspecified route of administration, on an unspecified date (Batch/Lot number was not reported) as dose 1, single for COVID-19 immunisation. The patient's medical history and patient's concomitant medications were not reported. The patient experienced fatigue and sore arms on an unspecified date, after receiving the first shot. The patient has concerns about getting the second shot because he heard of side effects from the second dose. The outcome of events fatigue and sore arms was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: pain at the injection site; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), dose 1 via an unspecified route of administration, on 26Feb2021 (Batch/Lot number was not reported) as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced pain at the injection site on 26Feb2021. The patient received no treatment for the event. The patient would like to know if it's okay to take paracetamol (TYLENOL) after the first dose. The outcome of event pain at the injection site was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.